• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.

作者信息

Swindle P, Falk M, Rigby R, Petrie J, Hawley C, Nicol D

机构信息

Department of Urology, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

Br J Urol. 1998 Feb;81(2):229-33. doi: 10.1046/j.1464-410x.1998.00496.x.

DOI:10.1046/j.1464-410x.1998.00496.x
PMID:9488064
Abstract

OBJECTIVES

To determine the incidence of transitional cell carcinoma (TCC) in a renal transplant population and to compare the pattern of neoplasia in patients with analgesic nephropathy (AN) with that in other patients.

PATIENTS AND METHODS

Using the Australia and New Zealand Dialysis and Transplant Registry, renal transplant recipients of the Princess Alexandra Hospital with TCC were identified. They were separated into two groups based on their primary disease, i.e. AN (group 1) and other causes of renal failure (group 2). The age at diagnosis of TCC, site, grade, stage of TCC and outcome were then compared between the groups.

RESULTS

There were 250 (15%) patients in group 1 and 1424 (85%) in group 2; seven patients in each group were found to have TCC, which thus occurred more frequently in the AN group (2.8%) than in group 2 (0.49%). In group 1, five patients died, four from metastatic disease; of these, the mean time from transplantation to diagnosis of the initial tumour was 4.4 years, with a mean time from diagnosis to death of 9 months. In contrast, there were no deaths from metastatic disease in group 2. In group 1, all patients had upper tract tumours, with five patients also having bladder involvement. The upper tract tumours tended to be of a high stage and grade (grade II-III) and were aggressive. In group 2, all the tumours were confined to the bladder and tended to be of low stage and grade (grade I-II Ta).

CONCLUSIONS

Patients undergoing renal transplantation as a result of AN are at high risk of developing TCCs of the upper urinary tracts. These tumours tend to be of a high grade and stage and the patients have a poor outcome. Screening with urine analysis and voided urine cytology do not appear to be reliable for the early diagnosis of upper renal tract TCCs in the renal transplant patient. We advocate annual cystoscopy and retrograde ureteric catheterization with washings, brushings and radiological imaging to diagnose upper tract TCCs at an early stage. These patients should also be screened before transplantation using the same technique.

摘要

相似文献

1
Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.
Br J Urol. 1998 Feb;81(2):229-33. doi: 10.1046/j.1464-410x.1998.00496.x.
2
The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.在欧洲区域性肾移植人群中管理移行细胞癌(TCC)。
BJU Int. 2012 Jul;110(2 Pt 2):E34-40. doi: 10.1111/j.1464-410X.2011.10777.x. Epub 2012 Jan 13.
3
A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.膀胱与上尿路移行细胞癌的病理学比较。
BJU Int. 2005 Apr;95(6):791-3. doi: 10.1111/j.1464-410X.2005.05402.x.
4
Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis.肾移植后原发性尿路移行细胞癌:长期回顾性分析后的建议。
Am J Med Sci. 2011 Jun;341(6):478-83. doi: 10.1097/MAJ.0b013e31820a87f7.
5
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.上尿路移行细胞癌行肾输尿管切除术或输尿管节段切除术后膀胱肿瘤的病理特征。
Urology. 2007 Feb;69(2):251-4. doi: 10.1016/j.urology.2006.09.065.
6
The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.膀胱移行细胞癌患者经尿道膀胱肿瘤切除术后上尿路细胞学检查的价值。
J Urol. 1999 Jan;161(1):77-9; discussion 79-80.
7
Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.首次诊断于上尿路的移行细胞癌的择期内镜治疗。
BJU Int. 2008 Nov;102(9):1107-10. doi: 10.1111/j.1464-410X.2008.07766.x. Epub 2008 Jun 3.
8
Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.上尿路移行细胞癌初次手术后的膀胱肿瘤复发。
Urol Int. 2004;73(3):209-11. doi: 10.1159/000080829.
9
Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.对于所有上尿路移行细胞癌病例,肾输尿管切除术是否必要?对侧肾脏正常的个体中上尿路移行细胞癌保守性腔内治疗的长期结果。
Urology. 2001 Aug;58(2):174-8. doi: 10.1016/s0090-4295(01)01109-8.
10
Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.排尿尿液及膀胱灌洗细胞学检查在检测尿路移行细胞癌中的诊断价值。
Urol Int. 1999;62(1):26-30. doi: 10.1159/000030350.

引用本文的文献

1
Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.肾移植受者中尿路上皮癌的mRNA和长链非编码RNA分析
Tumour Biol. 2016 Sep;37(9):12673-12684. doi: 10.1007/s13277-016-5148-1. Epub 2016 Jul 22.
2
Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.台湾肾移植术后终末期肾病患者的上尿路尿路上皮癌行为
Int Urol Nephrol. 2016 Aug;48(8):1261-1265. doi: 10.1007/s11255-016-1308-x. Epub 2016 May 18.
3
Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.
慢性肾脏病患者的上尿路尿路上皮癌:与诊断挑战的关系
Biomed Res Int. 2014;2014:989458. doi: 10.1155/2014/989458. Epub 2014 Aug 7.
4
Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.怀疑含有马兜铃酸的中草药产品的使用与终末期肾病(ESRD)患者患尿路癌风险增加有关。
PLoS One. 2014 Aug 29;9(8):e105218. doi: 10.1371/journal.pone.0105218. eCollection 2014.
5
Spectrum of cancer risk among US solid organ transplant recipients.美国实体器官移植受者的癌症风险谱。
JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.
6
Transitional cell carcinoma in renal transplant recipients.肾移植受者的移行细胞癌
World J Surg. 2003 Aug;27(8):912-6. doi: 10.1007/s00268-003-6954-3. Epub 2003 Jun 6.